About
Pulnovo Medical Limited is a medical device company founded in 2013 and headquartered in Wuxi, China. The company specializes in innovative treatments for pulmonary hypertension (PH) and heart failure (HF). With a strong international presence, Pulnovo Medical conducts clinical activities across the United States, Europe, Asia, and the Middle East, focusing on addressing critical needs in cardiovascular care. The company's flagship product is the Pulmonary Artery Denervation (PADN) System, which utilizes radiofrequency ablation technology to treat patients with pulmonary hypertension. The PADN system includes a multi-pole RF ablation catheter and generator, designed to reduce pulmonary artery pressure through a minimally invasive procedure. Pulnovo Medical is committed to expanding patient access to its therapies and has established partnerships with healthcare providers and payers to facilitate this goal. The company has achieved several regulatory milestones, including FDA Breakthrough Device Designation and CE-MDR certification, further solidifying its position in the global market.
Technologies
Keywords
Company Information
- Employees18
- Founded2013
- Annual Revenue$6300000
- Total Funding$15455472
Location
Shanghai, Shanghai, China
